We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4206:TSEAica Kogyo Company, Limited Analysis

Data as of 2026-06-13 - not real-time

¥3,491.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Aica Kogyo is trading at ¥3,491, comfortably above its 20‑day SMA of ¥3,435 but still below the 50‑day SMA of ¥3,512, indicating a short‑term pull‑back within a longer‑term bearish trend. The MACD histogram is positive (≈13) and the signal line is bullish, while the RSI sits at 54.7, suggesting neutral momentum with no immediate overbought pressure. Valuation metrics are attractive: a trailing P/E of 12.66 versus an industry average of 30.6, and a P/B of 1.16, positioning the stock as potentially undervalued. Dividend fundamentals are solid, with a 4.01% yield, a payout ratio near 50%, and ample cash generation (free cash flow ≈ ¥3.8 bn), supporting sustainability. However, the DCF‑derived fair value of roughly ¥1,094 signals a stark discrepancy, implying that market pricing may be driven by factors beyond pure cash‑flow models. Volatility is moderate at ~15.7% over 30 days, beta is near zero (‑0.05 computed, 0.196 quoted), and volume is trending upward, indicating decent liquidity. The stock’s upside potential is estimated at ~16% with analysts targeting ¥4,050, reinforcing a bullish bias despite the broader bearish trend. Geographic exposure spans Japan, China, and other Asian markets, adding diversification but also modest regional risk. Overall, the blend of cheap valuation, strong dividend, and supportive technical signals makes the stock appealing for investors seeking value with income, while remaining cautious of the price‑trend divergence.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at ¥3,510 with bearish trend direction
  • Positive MACD histogram indicating potential short‑term bounce
  • Strong dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Analyst target price of ¥4,050 suggesting ~16% upside
  • Sustainable dividend payout supporting total return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable cash flow generation and low beta reducing market volatility exposure
  • Attractive dividend yield and payout ratio for income‑focused investors
  • Diversified geographic footprint mitigating single‑region risk

Key Metrics & Analysis

Financial Health

Revenue Growth2.50%
Profit Margin7.36%
P/E Ratio12.7
ROE10.19%
ROA7.89%
Debt/Equity22.95
P/B Ratio1.2
Op. Cash Flow¥8.8B
Free Cash Flow¥3.8B
Industry P/E30.6

Technical Analysis

TrendBearish
RSI54.7
Support¥3,340.00
Resistance¥3,510.00
MA 20¥3,435.55
MA 50¥3,512.44
MA 200¥3,612.11
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value¥1,093.75
Target Price¥4,050.00
Upside/Downside16.01%
GradeUndervalued
TypeValue
Dividend Yield4.01%

Risk Assessment

Beta-0.05
Volatility15.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.